AIH:NSD-Aesthetic Medical Intl Holding Ltd (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 0.5269

Change

0.00 (0.00)%

Market Cap

USD 0.02B

Volume

2.13K

Analyst Target

USD 8.99
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-15 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

+0.33 (+0.27%)

USD 6.90B
ACHC Acadia Healthcare Company Inc

+0.18 (+0.26%)

USD 6.38B
OPCH Option Care Health Inc

+0.48 (+1.70%)

USD 4.85B
SGRY Surgery Partners Inc

-0.75 (-3.06%)

USD 3.21B
AMED Amedisys Inc

-0.12 (-0.13%)

USD 2.99B
LFST Lifestance Health Group Inc

+0.02 (+0.38%)

USD 2.02B
ADUS Addus HomeCare Corporation

+0.94 (+0.79%)

USD 1.95B
ASTH Astrana Health Inc

-0.60 (-1.45%)

USD 1.88B
HCSG Healthcare Services Group Inc

+0.14 (+1.38%)

USD 0.76B
INNV InnovAge Holding Corp

+0.36 (+7.58%)

USD 0.69B

ETFs Containing AIH

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -23.64% 46% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -23.64% 46% F 26% F
Trailing 12 Months  
Capital Gain -51.66% 23% F 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -51.66% 23% F 20% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -39.17% 8% B- 6% D-
Dividend Return -39.17% 8% B- 6% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 27.83% 85% B 66% D+
Risk Adjusted Return -140.73% 4% F 1% F
Market Capitalization 0.02B 12% F 15% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector